Individually Tailored and Integrated Social Support Network for Tobacco Cessation
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Smoking Cessation |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/2/2018 |
| Start Date: | May 30, 2017 |
| End Date: | November 30, 2018 |
Live Inspired: Individually Tailored and Integrated Social Support Network for Tobacco Cessation
This study will continue development of a quit smoking program delivered through text
messaging. Upon completion of programming we will enroll 280 participants and randomize them
to a control condition or the intervention condition. Assessments will occur at enrollment,
and both 3 and 6 month follow ups.
messaging. Upon completion of programming we will enroll 280 participants and randomize them
to a control condition or the intervention condition. Assessments will occur at enrollment,
and both 3 and 6 month follow ups.
This study builds on pilot work in which Live Inspired LLC and research partners developed
T2Q (formerly "Text-2-Quit") a smoking cessation intervention delivered through text
messaging. T2Q is a unique program with a number of features that provide superior support
and service compared to existing text message quit smoking products. T2Q is 100% accessible
through text messaging provides medication support for quitting smoking, an integrated social
support network and live counseling. This phase II project will add functionality to
accommodate use of multiple forms of quit smoking medications, and then conduct a rigorous
test of the efficacy of T2Q among 280 adult smokers and examine smoking outcomes compared to
controls at 3 and 6 months follow up. The study will also examine changes in smoking-related
attitudes and behaviors among T2Q users to identify strengths and any potential weaknesses
that may affect T2Q's impact on smoking outcomes. Analyses will examine the quality of social
interactions within the T2Q integrated social support network and their role in promoting
smoking abstinence. We will also conduct interviews with study participants in the T2Q arm to
enable understanding of the user's experience with T2Q. Results of this trial will
demonstrate the efficacy of T2Q - providing important credibility needed for successful
commercialization. This research will also provide important data for possible enhancements
to improve consumer appeal prior to commercialization.
This proposal finalizes development and testing of a unique, highly scalable intervention
that can reach a U.S. market comprised of over 34 million adult smokers who use text
messaging, and provide them with effective, evidence-based treatment. Text messaging enjoys
near-market saturation and is a widely preferred method of communication with deep
penetration across diverse groups. Wide availability of an attractive and effective smoking
cessation program such as T2Q, may exert a powerful, sustained impact on public health
T2Q (formerly "Text-2-Quit") a smoking cessation intervention delivered through text
messaging. T2Q is a unique program with a number of features that provide superior support
and service compared to existing text message quit smoking products. T2Q is 100% accessible
through text messaging provides medication support for quitting smoking, an integrated social
support network and live counseling. This phase II project will add functionality to
accommodate use of multiple forms of quit smoking medications, and then conduct a rigorous
test of the efficacy of T2Q among 280 adult smokers and examine smoking outcomes compared to
controls at 3 and 6 months follow up. The study will also examine changes in smoking-related
attitudes and behaviors among T2Q users to identify strengths and any potential weaknesses
that may affect T2Q's impact on smoking outcomes. Analyses will examine the quality of social
interactions within the T2Q integrated social support network and their role in promoting
smoking abstinence. We will also conduct interviews with study participants in the T2Q arm to
enable understanding of the user's experience with T2Q. Results of this trial will
demonstrate the efficacy of T2Q - providing important credibility needed for successful
commercialization. This research will also provide important data for possible enhancements
to improve consumer appeal prior to commercialization.
This proposal finalizes development and testing of a unique, highly scalable intervention
that can reach a U.S. market comprised of over 34 million adult smokers who use text
messaging, and provide them with effective, evidence-based treatment. Text messaging enjoys
near-market saturation and is a widely preferred method of communication with deep
penetration across diverse groups. Wide availability of an attractive and effective smoking
cessation program such as T2Q, may exert a powerful, sustained impact on public health
Inclusion Criteria:
- age >18
- current daily cigarette smoker
- use of text messaging at least once per week
- interested in quitting smoking within the next 30 days
- has access to a physician or healthcare provider
- no current drug/alcohol abuse.
Exclusion Criteria:
- Non-English Speaking
- Currently using quit-smoking medications or therapies
We found this trial at
1
site
Providence, Rhode Island 02903
Principal Investigator: Beth C Bock, PhD
Phone: 401-793-8020
Click here to add this to my saved trials
